NZ197997A - N-(3-(omega-aminoalkyl)-1-hindol-5-ylmethyl)hydrocarbyl - Google Patents

N-(3-(omega-aminoalkyl)-1-hindol-5-ylmethyl)hydrocarbyl

Info

Publication number
NZ197997A
NZ197997A NZ197997A NZ19799781A NZ197997A NZ 197997 A NZ197997 A NZ 197997A NZ 197997 A NZ197997 A NZ 197997A NZ 19799781 A NZ19799781 A NZ 19799781A NZ 197997 A NZ197997 A NZ 197997A
Authority
NZ
New Zealand
Prior art keywords
compound
group
general formula
methyl
formula
Prior art date
Application number
NZ197997A
Other languages
English (en)
Inventor
I H Coates
K Mills
C F Webb
M D Dowle
D E Bays
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NZ197997A publication Critical patent/NZ197997A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ197997A 1980-08-12 1981-08-11 N-(3-(omega-aminoalkyl)-1-hindol-5-ylmethyl)hydrocarbyl NZ197997A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8026288 1980-08-12

Publications (1)

Publication Number Publication Date
NZ197997A true NZ197997A (en) 1985-08-16

Family

ID=10515412

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ197997A NZ197997A (en) 1980-08-12 1981-08-11 N-(3-(omega-aminoalkyl)-1-hindol-5-ylmethyl)hydrocarbyl

Country Status (28)

Country Link
US (2) US4672067A (enExample)
JP (1) JPS5759864A (enExample)
AR (1) AR231533A1 (enExample)
AT (1) AT381304B (enExample)
AU (1) AU548270B2 (enExample)
BE (1) BE889930A (enExample)
CA (2) CA1169077A (enExample)
CH (1) CH651550A5 (enExample)
DE (1) DE3131748A1 (enExample)
DK (1) DK157680C (enExample)
ES (2) ES504695A0 (enExample)
FI (1) FI812475A7 (enExample)
FR (1) FR2488605A1 (enExample)
GB (1) GB2081717B (enExample)
GR (1) GR74536B (enExample)
IE (1) IE51492B1 (enExample)
IL (1) IL63541A (enExample)
IT (1) IT1171451B (enExample)
LU (1) LU83546A1 (enExample)
MY (1) MY8600577A (enExample)
NL (1) NL8103768A (enExample)
NO (1) NO812722L (enExample)
NZ (1) NZ197997A (enExample)
PH (1) PH17428A (enExample)
PT (1) PT73503B (enExample)
SE (1) SE454881B (enExample)
ZA (1) ZA815539B (enExample)
ZW (1) ZW19381A1 (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
HU196752B (en) * 1983-12-06 1989-01-30 Glaxo Group Ltd Process for production of medical compositions containing indole-derivatives and these compounds
GB8332434D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Production of chemical compounds
GB8332437D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
US4833153A (en) * 1985-11-08 1989-05-23 Glaxo Group Limited Indole derivatives
GB8530507D0 (en) * 1985-12-11 1986-01-22 Glaxo Group Plc Chemical compounds
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8600398D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
US5270333A (en) * 1986-01-28 1993-12-14 Glaxo Group Limited Indole derivatives
GB8607824D0 (en) * 1986-03-27 1986-04-30 Glaxo Group Ltd Chemical compounds
DE3613623A1 (de) * 1986-04-23 1987-10-29 Bayer Ag N-dihydroindolylethyl-sulfonamide
GB8615599D0 (en) * 1986-06-26 1986-07-30 Glaxo Group Ltd Chemical compounds
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
KR100215627B1 (ko) * 1990-06-07 1999-08-16 레슬리 제인 에드워즈 치료용 헤테로사이클 화합물
GB9022250D0 (en) * 1990-10-12 1990-11-28 Glaxo Group Ltd Medicaments
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
CA2091562C (en) * 1990-10-15 2001-03-27 John Eugene Macor Indole derivatives useful in psychotherapeutics
SK278998B6 (sk) * 1991-02-01 1998-05-06 Merck Sharp & Dohme Limited Deriváty imidazolu, triazolu a tetrazolu, spôsob i
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds
ES2033577B1 (es) * 1991-06-06 1995-01-16 Quimica Sint S A Con El 50 Procedimiento para la obtencion de la 2-carboxi-3-(2-(dimetilamino)etil)-n-metil-1h-indol-5-metanosulfonamida y sus esteres alquilicos inferiores.
ES2033578B1 (es) * 1991-06-06 1995-01-16 Quimica Sint S A Con El 50 Procedimiento para la obtencion de 3-(2-(dimetilamino)etil)-n-metil-1h-indol-5-metanosulfonamida.
GB9209882D0 (en) * 1992-05-07 1992-06-24 Glaxo Lab Sa Compositions
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
IL106445A (en) * 1992-07-30 1998-01-04 Merck Sharp & Dohme History of 1,2,4-Trans-Triazole 4-Transform, Preparation and Pharmaceutical Preparations Containing Them
CA2169179C (en) * 1993-08-31 2000-02-29 John E. Macor 5-arylindole derivatives
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
AU7261196A (en) * 1995-10-10 1997-04-30 Eli Lilly And Company N-{2-substituted-3-(2-aminoethyl)-1h-indol-5-yl}-amides: new 5-ht1f agonists
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
US20030096379A1 (en) * 2001-03-28 2003-05-22 Kilgore James L. Method for producing tryptamine derivatives
US7026364B2 (en) * 2001-04-13 2006-04-11 Organo Corporation Ion exchanger
JP5833804B2 (ja) * 2005-04-13 2015-12-16 ニューラクソン，インコーポレーテッド Ｎｏｓ阻害活性を有する置換インドール化合物
WO2017004501A1 (en) 2015-07-02 2017-01-05 Civitas Therapeutics, Inc. Triptan powders for pulmonary delivery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2870162A (en) * 1954-04-28 1959-01-20 Upjohn Co Production of certain tryptamines and compounds produced in the process
BE632051A (fr) * 1963-05-08 1963-11-18 Sandoz Sa Nouveaux dérivés de l'indole et leur préparation.
CH442303A (de) * 1964-06-26 1967-08-31 Sandoz Ag Verfahren zur Herstellung von neuen Indol-Derivaten
US3472870A (en) * 1966-08-29 1969-10-14 Mead Johnson & Co Sulfonamidotryptamines
FR2334358A1 (fr) * 1975-12-12 1977-07-08 Sogeras Nouveaux medicaments derives de l'indole
US4180509A (en) * 1977-07-01 1979-12-25 Merrell Toraude Et Compagnie α-Ethynyl tryptophanes
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
MY8600577A (en) 1986-12-31
ZW19381A1 (en) 1983-03-09
CA1169429A (en) 1984-06-19
DK357181A (da) 1982-02-13
AT381304B (de) 1986-09-25
BE889930A (fr) 1982-02-11
IE811831L (en) 1982-02-12
IT8149086A0 (it) 1981-08-11
DE3131748C2 (enExample) 1992-04-23
US4636521A (en) 1987-01-13
GB2081717B (en) 1983-09-28
SE8104782L (sv) 1982-02-13
PT73503A (en) 1981-09-01
JPH0148895B2 (enExample) 1989-10-20
IL63541A (en) 1985-08-30
ZA815539B (en) 1983-03-30
FR2488605A1 (fr) 1982-02-19
ES513935A0 (es) 1984-04-16
DK157680C (da) 1990-07-09
FR2488605B1 (enExample) 1984-11-16
CH651550A5 (fr) 1985-09-30
PT73503B (en) 1983-09-14
GR74536B (enExample) 1984-06-29
DK157680B (da) 1990-02-05
ES8300700A1 (es) 1982-11-01
CA1169077A (en) 1984-06-12
ATA352881A (de) 1986-02-15
IT1171451B (it) 1987-06-10
PH17428A (en) 1984-08-20
NO812722L (no) 1982-02-15
ES504695A0 (es) 1982-11-01
FI812475L (fi) 1982-02-13
US4672067A (en) 1987-06-09
IT8149086A1 (it) 1983-02-11
AU548270B2 (en) 1985-12-05
LU83546A1 (fr) 1983-06-08
NL8103768A (nl) 1982-03-01
JPS5759864A (en) 1982-04-10
SE454881B (sv) 1988-06-06
FI812475A7 (fi) 1982-02-13
GB2081717A (en) 1982-02-24
IE51492B1 (en) 1987-01-07
DE3131748A1 (de) 1982-04-01
AU7399681A (en) 1982-02-18
AR231533A1 (es) 1984-12-28
ES8404327A1 (es) 1984-04-16

Similar Documents

Publication Publication Date Title
US4636521A (en) 3 amino alkyl indoles for use in treating migraine
US4816470A (en) Heterocyclic compounds
US4839377A (en) 5-substituted 3-aminoalkyl indoles
US4650810A (en) Indole-5-acetamides for treatment of migraine
US5756507A (en) Antagonists of gonadotropin releasing hormone
AU704937B2 (en) Antagonists of gonadotropin releasing hormone
EP0147107B1 (en) Indole derivates
IE58122B1 (en) An indole derivative
GB2162522A (en) An indole derivative
WO1997021703A1 (en) Antagonists of gonadotropin releasing hormone
HU196752B (en) Process for production of medical compositions containing indole-derivatives and these compounds
JPS62228056A (ja) 化学的化合物
NZ197998A (en) 5-amino(methyl)-1h-indol-3-ylalkaneamines
GB2186874A (en) Pharmaceutically active 5-acylaminoalkyl-3-aminoalkyl-1H-indoles
US4870096A (en) 5-substituted 3-aninoalkyl indoles
GB2082175A (en) Heterocyclic compounds
GB2191488A (en) Indole derivatives
EP0785933B1 (en) Indole derivatives as 5ht1-like agonists
US4876267A (en) 5-Aminosulphoryl substituted indole derivatives